Oral anticoagulant therapy

Preview

The overall prescription of oral anticoagulants has steadily increased as important randomized clinical trials have clarified various indications for therapy. However, a number of practical matters related to initiation, monitoring, dose adjustment, and management are less frequently addressed. Moreover, this information can be difficult to find, even in major textbooks. Rather than providing a comprehensive review of oral anticoagulants, this article emphasizes various practical aspects of therapy.

Additional information

Notes on contributors

Malcolm L. Brigden

Malcolm L. Brigden, MD, FRCPC Dr Brigden is assistant head, hematology discipline, Metro-McNair Clinical Laboratories, Vancouver and Victoria, and consultant In hematology-oncology at Victoria General and Royal Jubilee hospitals, Victoria, British Columbia.